loading...

Pediatric Restless Legs Syndrome Severity Scale ® (P-RLS-SS)

Boehringer Ingelheim Pharma (Germany); Mapi

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Developed in 2010
A parent questionnaire P-RLS-SS-PQ was also developed to complement information from the child/adolescent scale

Authors

Boehringer Ingelheim Pharma (Germany); Mapi

Copyright
P-RLS-SS © Boehringer Ingelheim Pharma, 2010. All Rights Reserved.
Objective
To measure Pediatric Restless Legs Syndrome (P-RLS) symptom severity and impact on functionning
Therapeutic area
  • Nervous System Diseases
  • Mental Disorders
Therapeutic indication

Restless Legs Syndrome

Type of Clinical Outcome Assessment (COA)
  • obsro ObsRO
  • pro PRO
ObsRO: parent version / PRO: child version
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Arbuckle R, Abetz L, Durmer JS, Ivanenko A, Owens JA, Croenlein J, Bolton K, Moore A, Allen RP, Walters AS, Picchietti DL. Development of the Pediatric Restless Legs Syndrome Severity Scale (P-RLS-SS): a patient-reported outcome measure of pediatric RLS symptoms and impact. Sleep Med. 2010 Oct;11(9):897-906 (PubMed abstract)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use

Authors

Boehringer Ingelheim Pharma (Germany); Mapi

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students, physicians, clinical practice, not-funded academic users

You may access available translations of the questionnaire directly (see tutorial). Should you not see the Download button, please contact us.

Funded academic users, healthcare organizations, commercial users & IT companies

Fees may apply to your project. Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the USA

Translations

The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.

Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.

P-RLS-SS - Child version

Arabic for Egypt

P-RLS-SS - Parent version

Arabic for Egypt

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us